II
SRPT icon

Inspire Investing’s Sarepta Therapeutics SRPT Stock Holding History

Inspire Investing’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,241
Closed -$352K – 1171
2025
Q3 		$352K Sell
18,241
-9,459
-34% -$169K 0.03% 742
2025
Q2 		$474K Buy
27,700
+12,553
+83% +$536K 0.05% 296
2025
Q1 		$967K Buy
+15,147
New +$1.59M 0.11% 189
2024
Q1 		– Sell
-8,492
Closed -$819K – 864
2023
Q4 		$819K Buy
8,492
+2,894
+52% +$278K 0.09% 237
2023
Q3 		$679K Sell
5,598
-14,515
-72% -$1.64M 0.09% 229
2023
Q2 		$2.3M Buy
20,113
+3,032
+18% +$391K 0.28% 85
2023
Q1 		$2.35M Buy
17,081
+2,937
+21% +$381K 0.3% 82
2022
Q4 		$1.83M Buy
14,144
+12,277
+658% +$1.42M 0.24% 93
2022
Q3 		$206K Sell
1,867
-933
-33% -$94K 0.03% 665
2022
Q2 		$210K Sell
2,800
-201
-7% -$14.8K 0.03% 748
2022
Q1 		$234K Buy
3,001
+232
+8% +$17.8K 0.03% 719
2021
Q4 		$249K Buy
2,769
+195
+8% +$16.7K 0.03% 531
2021
Q3 		$238K Buy
+2,574
New +$198K 0.03% 440
2018
Q1 		– Sell
-1,082
Closed -$60K – 631
2017
Q4 		$60K Buy
+1,082
New +$57.3K 0.05% 314

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Inspire Investing's SRPT Position: Q4 2025 in Review

Inspire Investing sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 18,241 shares — an estimated $352K sold.

Inspire Investing first reported a position in SRPT in Q4 2017 and held it in 14 quarters. The position peaked at $2.35M in Q1 2023. 347 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Inspire Investing reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Inspire Investing sold 18,241 Sarepta Therapeutics shares in Q4 2025, an estimated $352K.
  • Inspire Investing first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 14 quarters.
  • Inspire Investing's Sarepta Therapeutics position peaked at $2.35M in Q1 2023.
  • 347 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Inspire Investing's 13F filing for Q4 2025, filed 17 Feb 2026.